Insider trades
David Owens, Chief Officer of Nexalin Technology NXL, has filed 11 purchases and 0 sales on the open market. The latest trade was on 25/12/19.
David Owens
Chief Medical Officer
- Company
- Nexalin Technology NXL
- First filing
- 23/10/05
- Trades
- 19 trades
- Buys / sales
- 11 / 0
- 12-month net buying
- No record
- Last trade
- 25/12/19
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market buy | 25/02/04 | 25/02/05 | 1,000 sh | $3.10 | $3,100 | +0.6% | |
| Open-market buy | 25/02/04 | 25/02/04 | 1,000 sh | $2.98 | $2,980 | +0.7% | |
| Open-market buy | 25/01/28 | 25/01/29 | 1,500 sh | $2.70 | $4,050 | +1.0% | |
NXL | Open-market buy | 25/01/13–25/01/23 | 25/01/24 | 3,000 sh2 trades | $2.57avg. | $7,700 | +2.0% |
| Open-market buy | 24/10/28 | 24/10/30 | 500 sh | $2.19 | $1,095 | +0.3% | |
| Open-market buy | 24/08/13 | 24/08/15 | 1,000 sh | $0.95 | $950 | +0.7% | |
| Open-market buy | 24/06/28 | 24/07/01 | 1,000 sh | $1.75 | $1,750 | +0.7% | |
| Open-market buy | 24/06/18 | 24/06/21 | 1,619 sh | $0.71 | $1,149.49 | +1.1% | |
NXL | Open-market buy | 24/06/10 | 24/06/12 | 3,000 sh2 trades | $0.64avg. | $1,920 | +2.1% |